Century Therapeutics, Inc.

NASDAQ:IPSC

0.6163 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 76.56-36.073-31.224-31.207-28.062-39.398-32.72-33.291-31.264-31.682-30.749-30.988-37.513-28.194-26.009-23.273-18.348-15.531-13.07-15.301-9.673
Depreciation & Amortization 3.2213.3183.2983.4623.2263.5523.353.2342.9082.8382.7741.6681.161.0511.0440.9350.7180.510.410.2820.2
Deferred Income Tax 00.87000-13.55304.22000000000004.7220
Stock Based Compensation 2.4262.663.3183.5033.2073.5623.9783.2853.7972.7322.7862.7712.381.6361.221.7110.0950.3740.1440.1370.221
Change In Working Capital 01.83-2.7750.713-9.046-2.91112.184.089-3.9782.5910.4120.48120.4620.826-0.5231.849-4.9491.2173.167-1.8312.309
Accounts Receivables 000000000000000000000
Change In Inventory 000000000000000000000
Change In Accounts Payables 0.3610.477-0.757-1.8780.689-2.8873.994-0.514-2.954-1.6330.706-2.358-1.5032.292-0.5781.376-4.938-0.341.605-0.831.627
Other Working Capital 01.353-2.0182.591-9.735-0.0248.1864.603-1.0244.224-0.2942.838121.965-1.4660.0550.473-0.0111.5571.562-1.0010.682
Other Non Cash Items 04.042-0.9498.5029.39722.518-0.437-0.787-0.6820.6140.5380.5140.2640.330.2850.2890.3050.210.1240.0510.059
Operating Cash Flow -34.623-24.223-28.332-27.332-30.248-26.23-13.649-19.25-29.219-22.907-24.239-25.55586.753-24.351-23.983-18.489-22.179-13.22-9.225-11.94-6.884
Investing Activities:
Investments In Property Plant And Equipment 000.804-0.265-0.539-0.98-3.265-4.5-4.991-6.268-9.812-10.457-4.067-16.721-15.736-10.629-1.884-1.904-4.506-0.716-2.699
Acquisitions Net 000-9.608092.148-7.482-11.474-73.192-238.218-32.476-22.975-55.227-30.33600000-4.7220
Purchases Of Investments 0-17.403-13.198-53.86-35.087-9.692-57.499-99.014-42.829-50.337-66.382-34.221-103.06-41.888-146.077-17.219-124.85-36.927-8.518-2.936-1.479
Sales Maturities Of Investments -14.88548.18451.57229.86947.16729.27564.981110.48879.15852.33298.85857.19663.0938.00714.75916.27.718.0513.510.10
Other Investing Activites 42.815-0.1750.021-23.99112.0819.5837.48211.47473.192238.21832.47622.97555.22730.336-131.318-1.019-117.15-18.8774.982-4.722-1.479
Investing Cash Flow 27.9330.60639.199-33.86411.54118.6034.2176.97431.338-4.27322.66412.518-44.037-20.602-147.054-11.648-119.034-20.7810.4761.726-4.178
Financing Activities:
Debt Repayment 000000000000000000000
Common Stock Issued 0.12-0.6020.27356.69718.195-0.3560.30.1240.4480.0950.1370.04826.8780.0830221.9520.0470000
Common Stock Repurchased 000000000000000000000
Dividends Paid 000000000000000000000
Other Financing Activities 0000000-10.241000.001000.0230.0012.697193.43838.19.601-0.0110
Financing Cash Flow 0.12-0.6020.27356.69718.195-0.3560.3-10.1170.4480.0950.1380.04726.8780.106-0.466224.649193.48538.19.601-0.0110
Other Information:
Effect Of Forex Changes On Cash 000000000000000000000
Net Change In Cash -6.5735.78113.975-5.355-0.512-7.983-9.132-22.3932.567-27.085-1.437-12.9969.594-44.847-171.503194.51252.2724.0990.852-10.225-11.062
Cash At End Of Period 54.6461.21355.43241.45746.81247.32457.28666.41888.81186.244113.329114.766127.75658.162103.009274.5128027.72823.62922.77733.002